 |
|
Studies on combat related substance use and abuse to be funded by NIH and VA
(Posted: 08/26/2010) - Eleven research institutions in 11 states will receive more than $6 million in federal funding from fiscal year 2011 to support research on substance abuse and associated problems among U.S. military personnel, veterans, and their families. The National Institute on Drug Abuse is collaborating with the Department of Veterans Affairs, to award grants that will examine substance abuse related to deployment and combat related trauma. The National Institute on Alcohol Abuse and Alcoholism and the NCI are also NIH partners in this endeavor.
New breast cancer committee to establish federal research agenda
(Posted: 08/16/2010) - A newly formed advisory committee will develop and coordinate a strategic federal research agenda on environmental and genetic factors related to breast cancer. The 19-member Interagency Breast Cancer and Environmental Research Coordinating Committee (IBCERCC) was established by the National Institute of Environmental Health Sciences in collaboration with NCI to review all breast cancer research efforts conducted or supported by federal agencies.
Harold Varmus Sworn in as National Cancer Institute's 14th Director
(Posted: 07/12/2010) - Harold E. Varmus, M.D., today took the oath of office to become NCI’s 14th director. “It’s very exciting to have you back,” said Health and Human Services Secretary Kathleen Sebelius during the swearing-in ceremony. “Today is the opening of a new chapter for NCI.” Varmus was director of NIH from 1993 until the end of 1999.
 
News Note: NCI Scientists Identify a New Inflammatory Syndrome
(Posted: 06/29/2010) - NCI scientists have identified a new inflammatory condition called interleukin-6 syndrome caused by Kaposi’s sarcoma-associated herpesvirus (KSHV) in some people with HIV/AIDS. This syndrome will be added to three existing types of KSHV-linked illnesses in people with HIV/AIDS.
News Note: New NCI Program Will Help Aid Development and Validation of Tests Used in Cancer Clinical Trials
(Posted: 06/21/2010) - In order to conduct rigorous and robust clinical trials, the tests, or assays, used in those trials must meet optimum standards. To bring those assays and standards in line with 21st century technology, NCI's Division of Cancer Treatment and Diagnosis has started a new program called the Clinical Assay Development Program (CADP) to facilitate development and validation of clinical assays.
Vitamin D Status Is Not Associated With Risk for Less Common Cancers
(Posted: 06/18/2010) - Despite hopes that higher blood levels of vitamin D might reduce cancer risk, a large study finds no protective effect against non-Hodgkin lymphoma or cancer of the endometrium, esophagus, stomach, kidney, ovary, or pancreas. In this study, carried out by researchers from the NCI and many other research institutions, data based on blood samples originally drawn for 10 individual studies were combined to investigate whether people with high levels of vitamin D were less likely to develop these rarer cancers.
Scientists Identify Markers on Human Breast Cancer Cells Linked to Development of an Aggressive, But Less Common Form of Breast Cancer
(Posted: 05/18/2010) - Scientists have identified a group of surface markers on cells linked to an aggressive type of breast cancer called estrogen receptor-negative cancer. The research, conducted by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, appeared online May 18, 2010, and in print June 1, 2010, in Cancer Research.
NCI Statement: International Study Shows No Increased Risk of Brain Tumors from Cell Phone Use
(Posted: 05/17/2010) - Interphone, an international collaboration, and the largest study of its kind to date, reported that overall, cell phone users have no increased risk of two of the most common forms of brain cancer -- glioma and meningioma.
1 2 3 Next >
 View Archive of News Releases
|
|
|
Twitter
YouTube
Facebook
RSS